Bio-Thera Moves Ahead With Secukinumab And Mepolizumab

Chinese Player’s Biosimilar Rivals To Cosentyx And Nucala Take Steps Forward

 
• By David Wallace
  
Clinical Trial Icon
Bio-Thera has revealed the latest details of its biosimilar trials • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products